BiotechTube
Home/Inthera Bioscience/Frank Hennecke, PhD
FH

Frank Hennecke, PhD

Head of CMC Development

Inthera Bioscience

Therapeutic Areas

Oncology

Inthera Bioscience Pipeline

DrugIndicationPhase
INTH-454Advanced Prostate Cancer (CRPC) and Colorectal Cancer (CRC)IND-ready / Pre-clinical

Leadership Team at Inthera Bioscience

MK
Mark Krul
Chief Executive Officer
BH
Bernd Hentsch, PhD
Chief Development Officer
KA
Kim Andersen, PhD
Head of Drug Discovery
CA
Catherine Ammann
Head HR & Administration
View full Inthera Bioscience profile